Association between specific timothy grass antigens and changes in TH1- and TH2-cell responses following specific immunotherapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2014-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jaci.2014.05.033PMID 25042980PMCID PMC4253970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals

  2013cited by this paper
• A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population

  2013cited by this paper
• A Nonallergenic Birch Pollen Allergy Vaccine Consisting of Hepatitis PreS–Fused Bet v 1 Peptides Focuses Blocking IgG toward IgE Epitopes and Shifts Immune Responses to a Tolerogenic and Th1 Phenotype

  2013cited by this paper
• Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens.

  2013cited by this paper
• Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

  2013cited by this paper
• Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.

  2012cited by this paper
• Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes

  2011cited by this paper
• Birch Pollen Immunotherapy Leads to Differential Induction of Regulatory T Cells and Delayed Helper T Cell Immune Deviation

  2010cited by this paper
• Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen

  2010cited by this paper
• Peptide binding predictions for HLA DR, DP and DQ molecules

  2010cited by this paper
• A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach

  2008cited by this paper
• Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.

  2007cited by this paper
• The burden of allergic rhinitis.

  2007cited by this paper
• Predicting population coverage of T-cell epitope-based diagnostics and vaccines

  2006cited by this paper
• Hypoallergens for Allergen-specific Immunotherapy by Directed Molecular Evolution of Mite Group 2 Allergens*

  2006cited by this paper
• Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.

  2006cited by this paper
• Fel d 1‐derived T cell peptide therapy induces recruitment of CD4+CD25+; CD4+ interferon‐γ+ T helper type 1 cells to sites of allergen‐induced late‐phase skin reactions in cat‐allergic subjects

  2005cited by this paper
• Rational design of hypoallergens applied to the major cat allergen Fel d 1

  2005cited by this paper
• Primary structure, recombinant expression, and molecular characterization of Phl p 4, a major allergen of timothy grass (Phleum pratense).

  2005cited by this paper
• The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

  2004cited by this paper
• Prevalence and rate of diagnosis of allergic rhinitis in Europe

  2004cited by this paper
• Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells

  2004cited by this paper
• Characteristics and Immunobiology of Grass Pollen Allergens

  2003cited by this paper
• Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial.

  2003cited by this paper
• New allele frequency database: http://www.allelefrequencies.net.

  2003cited by this paper
• Specific immunotherapy prevents increased levels of allergen‐specific IL‐4‐ and IL‐13‐producing cells during pollen season

  2001cited by this paper
• Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy.

  2000cited by this paper
• Interleukin-13: central mediator of allergic asthma

  1998cited by this paper
• Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

  1998cited by this paper
• Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany.

  1998cited by this paper
• Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats.

  1998cited by this paper
• Interleukin-13: central mediator of allergic asthma.

  1998cited by this paper
• Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T‐cell clones specific for Phi p 1, a major grass pollen allergen

  1997cited by this paper
• Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

  1996cited by this paper
• Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p2, Phl p 5).

  1996cited by this paper
• Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.

  1995cited by this paper
• Regulation of the development of type 2 T-helper cells in allergy.

  1994cited by this paper
• T cells and eosinophils in the pathogenesis of asthma.

  1992cited by this paper
• Role of type 1 and type 2 T helper cells in allergic diseases.

  1992cited by this paper

• The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses

  2023cites this paper
• Sublingual Immunotherapy: How Sublingual Allergen Administration Heals Allergic Diseases; Current Perspective about the Mode of Action

  2021cites this paper
• The emerging role of type 2 inflammation in asthma

  2020cites this paper
• Intranasal nanoemulsion vaccine confers long‐lasting immunomodulation and sustained unresponsiveness in a murine model of milk allergy

  2020cites this paper
• Treatment of allergic disease with nanoemulsion adjuvant vaccines

  2020cites this paper
• Nanoemulsion adjuvant–driven redirection of TH2 immunity inhibits allergic reactions in murine models of peanut allergy

  2018cites this paper
• Experimental validation of the RATE tool for inferring HLA restrictions of T cell epitopes

  2017cites this paper
• Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper

  2017cites this paper
• Natural protective immunity against grass pollen allergy is maintained by a diverse spectrum of response types.

  2017cites this paper
• Molecular fingerprinting of complex grass allergoids: size assessments reveal new insights in epitope repertoires and functional capacities

  2017cites this paper
• Immunodominance in allergic T-cell reactivity to Japanese cedar in different geographic cohorts.

  2016cites this paper
• Sequence conservation predicts T cell reactivity against ragweed allergens

  2016cites this paper
• T-cell epitope conservation across allergen species is a major determinant of immunogenicity.

  2016cites this paper
• Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen‐specific immunotherapy

  2016cites this paper
• Grass pollen immunotherapy: where are we now.

  2016cites this paper
• Efficacy of sublingual immunotherapy for cedar pollinosis: A systematic review and meta-analysis.

  2016cites this paper
• T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy

  2016cites this paper
• Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergens

  2015cites this paper
• Clinical and cytokine responses to house dust mite sublingual immunotherapy.

  2015cites this paper
• Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys

  2015cites this paper
• Effects of desloratadine citrate disodium injection on rat models of ovalbumin‐induced allergic rhinitis: involvement of T‐cell responses modulation

  2015cites this paper
• Analysis of IgE binding patterns to house dust mite allergens in scabies‐endemic communities: insights for both diseases

  2015cites this paper
• Fine characterization of immunological mechanisms mediated by the major allergens of Parietaria judaica and by a hypoallergenic hybrid, rPjEDcys.

  2015cites this paper
• A Population Response Analysis Approach To Assign Class II HLA-Epitope Restrictions

  2015cites this paper
• Different Bla‐g T cell antigens dominate responses in asthma versus rhinitis subjects

  2015cites this paper
• Allergy-associated T cell epitope repertoires are surprisingly diverse and include non-IgE reactive antigens

  2014cites this paper
• New Strategies for Allergen T Cell Epitope Identification: Going beyond IgE

  2014influential citation